This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Centro De Ingenieria Genetica Y Biotecnologia, Centro De Inmunologia Molecular. Active years: 2015-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Camaguey, CU (2015 - 2016)
- Camagüey, CU (2023)
Company Filing History:

Years Active: 2015-2025
Title: The Innovative Contributions of Jesús Arturo Junco Barranco
Introduction: Jesús Arturo Junco Barranco is a notable inventor based in Camagüey, Cuba, recognized for his significant contributions to the field of immunology. With a focus on the development of advanced vaccine adjuvants, Junco Barranco has produced two notable patents that enhance vaccine efficacy.
Latest Patents: One of his latest patents involves "Nano-particles that contain synthetic variants of GM3 ganglioside as adjuvants in vaccines." This invention outlines methods for creating nano-particulated adjuvants from various synthetic variants of GM3 ganglioside. These adjuvants are designed to stimulate both humoral and cellular immune responses specifically against accompanying antigens, based on the structure of the fatty acids in the ceramide of the synthetic GM3. Furthermore, this invention provides immunogenic vaccine compositions that integrate peptides, polypeptides, or proteins with the described nanoparticles formed through the dispersion of hydrophobic proteins of the outer membrane complex in solutions containing these fully synthetic variants.
Career Highlights: Jesús Arturo Junco Barranco works at the Centro de Inmunología Molecular, where he has made impactful advancements in vaccine development. His work focuses on integrating innovative biological materials to create more effective immunological responses, positioning him as a leader in the field of immunological research.
Collaborations: Throughout his career, Junco Barranco has collaborated with notable colleagues, including Luis Enrique Fernández Molina and Belinda Sánchez Ramírez. These collaborations have fostered an environment of shared knowledge and innovation, enhancing the quality and reach of their collective research efforts.
Conclusion: Jesús Arturo Junco Barranco is a prominent inventor whose work in vaccine adjuvants is paving the way for significant advancements in immunology. His innovative patents and collaborations continue to impact the field positively, showcasing the importance of research and development in creating effective healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile